£74.00

It has never been this cheap. We have no record of a lower price.

£74 today · cheaper than every other day in the last 3 months

Untersuchung einer neuen Behandlungsmöglichkeit von Brustkrebs

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 23 days · 23 data points (no recent data)

Historical
Generating forecast…
£74.00 £70.30 £71.78 £73.26 £74.74 £76.22 £77.70 01 August 2026 06 August 2026 12 August 2026 17 August 2026 23 August 2026
View at Amazon ↗

Price data last checked 68 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 23 days • 1 price levels

Days at Price
23 days 0 6 12 17 23 £74 Days at Price

Price Analysis

Most common price: £74 (23 days, 100.0%)

Price range: £74 - £74

Price levels: 1 different prices over 23 days

Description

Brustkrebs ist gekennzeichnet durch maligne Tumoren, die invasiv in das umliegende Gewebe eindringen. Etwa 98% aller malignen Tumoren der Mamma sind Karzinome. Im Rahmen dieser Studie soll die Wirksamkeit einer neuen zusätzlichen Behandlungsmöglichkeit experimentell anhand von Zellversuchen untersucht werden. Es handelt sich dabei um eine selektive Behandlung von soliden malignen Tumoren durch Schallexposition. Diese Methode basiert auf den unterschiedlichen schwingungsmechanisch relevanten Eigenschaften von Tumorzellen im Vergleich zu gesunden Zellen. Eine Beschallung der Zellen sollte demzufolge in einer unterschiedlichen Wirkung auf die Zellen resultieren. Durch einen theoretisch zu erwartenden nichtkavitativ-nichtthermischen Effekt als Wirkungsmechanismus sollte es möglich sein, Tumorzellen durch Beschallung selektiv letal zu schädigen. Dazu sollen die Einflüsse der Behandlungsparameter Frequenz und Schallintensität und deren Wechselwirkungen auf die letale Zellschädigung innerhalb eines definierten Untersuchungsbereiches ermittelt und dabei die wirksamsten Parameterkombinationen aus Frequenz und Schallintensität gefunden werden.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
15 June 2010
Listed Since
23 June 2010

Barcode

No barcode data available

Similar Products You Might Like

"ErbB2 signaling in breast cancer": "the role of ErbB, Akt and ShcA phosphorylation"
87% match

"ErbB2 signaling in breast cancer": "the role of ErbB, Akt and ShcA phosphorylation"

Südwestdeutscher Verlag für Hochschulschriften

£68.00 23 Aug 2026
The Future of Prevention and Treatment of Breast Cancer
86% match

The Future of Prevention and Treatment of Breast Cancer

Springer

£92.22 24 Oct 2026
CDK4/6 inhibitors in Breast Cancer Therapy
85% match

CDK4/6 inhibitors in Breast Cancer Therapy

Elsevier

£153.99 20 Oct 2026
Nano Theragnostics in Breast Cancer: Advances, Challenges, and Future Prospects
85% match

Nano Theragnostics in Breast Cancer: Advances, Challenges, and Future Prospects

Springer

£147.11 21 Oct 2026
Early Onset Breast Cancer: Epidemiology, Pathobiology, Diagnosis, Treatment, and Survivorship
85% match

Early Onset Breast Cancer: Epidemiology, Pathobiology, Diagnosis, Treatment, and Survivorship

Springer

£129.99 22 Oct 2026
Current Advances in Breast Cancer Research: A Molecular Approach
84% match

Current Advances in Breast Cancer Research: A Molecular Approach

Bentham Science Publishers

£90.05 27 Oct 2026
Therapeutic potential of Cell Cycle Kinases in Breast Cancer
84% match

Therapeutic potential of Cell Cycle Kinases in Breast Cancer

Springer

£142.07 26 Oct 2026
Breast Cancer: Advances in Cellular and Molecular Biology
84% match

Breast Cancer: Advances in Cellular and Molecular Biology

£117.68 29 Oct 2026
Breast Cancer Immunotherapy
84% match

Breast Cancer Immunotherapy

Springer

£65.61 24 Oct 2026
Neuroendocrine tumours of the digestive tract in Austria: Incidence, diagnosis and treatment
84% match

Neuroendocrine tumours of the digestive tract in Austria: Incidence, diagnosis and treatment

Südwestdeutscher Verlag für Hochschulschriften

£79.00 20 Aug 2026
Ductal Carcinoma in Situ of the Breast
84% match

Ductal Carcinoma in Situ of the Breast

Springer

£95.74 22 Oct 2026
Management of Early Stage Breast Cancer: Basics and Controversies
83% match

Management of Early Stage Breast Cancer: Basics and Controversies

Springer

£58.39 20 Oct 2026
Investigating the Incidence Rate of Breast, Uterine: and Ovarian Cancer in Women based on Prevention and Treatment Tips
83% match

Investigating the Incidence Rate of Breast, Uterine: and Ovarian Cancer in Women based on Prevention and Treatment Tips

VDM Verlag

£63.00 20 Aug 2026
Breast Cancer Pathophysiology: An Interdisciplinary Approach: 5 (Interdisciplinary Cancer Research, 5)
83% match

Breast Cancer Pathophysiology: An Interdisciplinary Approach: 5 (Interdisciplinary Cancer Research, 5)

Springer

£169.50 20 Oct 2026
A Clinician's Guide to Breast Cancer
83% match

A Clinician's Guide to Breast Cancer

States Academic Press

£128.58 15 Aug 2026
A New Approach to Diagnosis and Treatment of Prostate Cancer
83% match

A New Approach to Diagnosis and Treatment of Prostate Cancer

£110.26 27 Oct 2026
Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)
83% match

Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)

Springer

£127.59 20 Oct 2026
Squamous cell Carcinoma: Molecular Therapeutic Targets
83% match

Squamous cell Carcinoma: Molecular Therapeutic Targets

Springer

£111.44 22 Oct 2026
New Research on Hematological Malignancies (Cancer Etiology, Diagnosis and Treatments)
83% match

New Research on Hematological Malignancies (Cancer Etiology, Diagnosis and Treatments)

£58.64 27 Oct 2026
Neuroendocrine Neoplasia Management: New Approaches for Diagnosis and Treatment
83% match

Neuroendocrine Neoplasia Management: New Approaches for Diagnosis and Treatment

Springer

£73.85 27 Oct 2026
Current Progress in Cancer Treatments
83% match

Current Progress in Cancer Treatments

£120.55 15 Aug 2026
Personalized Cancer Medicine through Multiomics
83% match

Personalized Cancer Medicine through Multiomics

Elsevier

£157.99 22 Oct 2026
The goodbye Breast Cancer
83% match

The goodbye Breast Cancer

LAP Lambert Academic Publishing

£63.00 09 Sep 2026
Targeted Therapies in Cancer: An Update (Cancer Etiology, Diagnosis and Treatments)
83% match

Targeted Therapies in Cancer: An Update (Cancer Etiology, Diagnosis and Treatments)

£90.58 23 Oct 2026